|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3800 AUD | +1.33% |
|
+1.33% | -41.54% |
| 07-30 | Recce Pharmaceuticals in Position to Benefit from US ASPR Medical Countermeasures Strategy | MT |
| 07-21 | Recce Pharmaceuticals Reports Higher Cash Balance in June Quarter | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.33% | +1.33% | 0.00% | -20.83% | -41.54% | +2.70% | -37.70% | -58.24% | +52.00% | 79.22M | |
| +4.86% | -3.32% | -3.63% | +18.30% | +8.86% | +52.73% | +160.26% | +342.81% | +1,334.36% | 1,043B | |
| +1.04% | -2.99% | -2.07% | +14.21% | +24.47% | +50.87% | +52.38% | +48.30% | +107.33% | 621B | |
| +0.98% | -6.49% | -5.70% | +19.45% | +7.75% | +24.00% | +66.66% | +113.86% | +270.00% | 435B | |
| +0.58% | +3.51% | +10.25% | +13.64% | +11.46% | +47.14% | +38.12% | +3.55% | +47.98% | 361B | |
| +0.85% | -1.07% | +0.26% | +8.46% | +14.43% | +35.78% | +39.59% | +50.20% | +55.13% | 293B | |
| +0.16% | -5.22% | -14.50% | -11.13% | -12.57% | +9.06% | +10.75% | +47.80% | +132.29% | 251B | |
| +4.57% | +5.21% | +9.00% | +23.74% | +24.60% | +35.91% | +67.64% | +74.29% | +134.84% | 220B | |
| +1.86% | -9.10% | -6.32% | +2.66% | -7.52% | +3.90% | -44.88% | -4.04% | +89.18% | 201B | |
| -2.58% | -0.73% | +0.37% | -1.29% | +7.35% | +17.16% | +67.46% | +90.13% | +63.86% | 164B | |
| +1.57% | +2.62% | +6.13% | -2.42% | +3.65% | +4.28% | -26.30% | -42.72% | -27.17% | 147B | |
| -3.43% | +0.84% | +9.46% | +11.73% | +17.96% | +38.78% | +5.19% | -7.00% | +0.55% | 130B | |
| +1.28% | +0.31% | -8.18% | +14.25% | +6.94% | +29.29% | +42.40% | +138.84% | +373.33% | 123B | |
| +1.08% | -0.05% | -2.21% | +3.42% | +6.28% | +41.23% | +43.40% | +8.00% | -7.55% | 103B | |
| +0.78% | +3.24% | +0.83% | +0.66% | -9.18% | -5.70% | -20.30% | -12.89% | +3.99% | 103B | |
| +1.14% | -4.34% | -10.30% | -16.44% | -17.94% | -8.75% | +61.93% | +69.06% | +462.11% | 69.83B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| +0.37% | +2.15% | -3.32% | +28.49% | +33.69% | +98.12% | -5.52% | +5.23% | -48.46% | 55.83B | |
| +2.96% | -5.12% | -1.67% | +2.17% | +12.20% | +27.98% | +24.06% | +49.53% | +15.57% | 53.39B | |
| +0.22% | -0.65% | -1.67% | -0.63% | -10.12% | -14.06% | +30.36% | -4.05% | +229.14% | 52.37B | |
| Average | +1.02% | -2.67% | -1.23% | +5.71% | +4.25% | +25.81% | +30.29% | +48.04% | +173.08% | 224.53B | |
| Weighted average by Cap. | +1.04% | -3.40% | -1.52% | +11.38% | +9.55% | +35.43% | +64.37% | +115.74% | +403.18% |
- Stock Market
- Stocks
- RCE Stock
- Sector Recce Pharmaceuticals Ltd
Select your edition
All financial news and data tailored to specific country editions
